CoChat

PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity

Open access
Incio, Joao, Tam, Josh, Rahbari, Nuh N., Suboj, Priya, McManus, Dan T., Chin, Shan M., Vardam, Trupti D., Batista, Ana, Babykutty, Suboj, Jung, Keehoon, Khachatryan, Anna, Hato, Tai, Ligibel, Jennifer A., Krop, Ian E., Puchner, Stefan B., Schlett, Christopher L., Hoffmman, Udo, Ancukiewicz, Marek, Shibuya, Masabumi, Carmeliet, Peter, Soares, Raquel, Duda, Dan G., Jain, Rakesh K., Fukumura, Dai · 2016 · Clinical Cancer Research
Cited by 134

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Purpose: Obesity promotes pancreatic and breast cancer progression via mechanisms that are poorly understood. Although obesity is associated with increased systemic levels of placental growth factor (PlGF), the role of PlGF in obesity-induced tumor progression is not known. PlGF and its receptor VEGFR-1 have been shown to modulate tumor angiogenesis and promote tumor-associated macrophage (TAM) recruitment and activity. Here, we hypothesized that increased activity of PlGF/VEGFR-1 signaling mediates obesity-induced tumor progression by augmenting tumor angiogenesis and TAM recruitment/activity. Experimental Design: We established diet-induced obese mouse models of wild-type C57BL/6, VEGFR-1 tyrosine kinase (TK)-null, or PlGF-null mice, and evaluated the role of PlGF/VEGFR-1 signaling in pancreatic and breast cancer mouse models and in human samples. Results: We found that obesity increased TAM infiltration, tumor growth, and metastasis in pancreatic cancers, without affecting vessel density. Ablation of VEGFR-1 signaling prevented obesity-induced tumor progression and shifted the tumor immune environment toward an antitumor phenotype. Similar findings were observed in a breast cancer model. Obesity was associated with increased systemic PlGF, but not VEGF-A or VEGF-B, in pancreatic and breast cancer patients and in various mouse models of these cancers. Ablation of PlGF phenocopied the effects of VEGFR-1-TK deletion on tumors in obese mice. PlGF/VEGFR-1-TK deletion prevented weight gain in mice fed a high-fat diet, but exacerbated hyperinsulinemia. Addition of metformin not only normalized insulin levels but also enhanced antitumor immunity. Conclusions: Targeting PlGF/VEGFR-1 signaling reprograms the tumor immune microenvironment and inhibits obesity-induced acceleration of tumor progression. Clin Cancer Res; 22(12); 2993–3004. ©2016 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-15-1839

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 134

Metadata

Authors
Incio, J., Tam, J., Rahbari, N. N., Suboj, P., McManus, D. T., Chin, S. M., Vardam, T. D., Batista, A., Babykutty, S., Jung, K., Khachatryan, A., Hato, T., Ligibel, J. A., Krop, I. E., Puchner, S. B., Schlett, C. L., Hoffmman, U., Ancukiewicz, M., Shibuya, M., Carmeliet, P., Soares, R., Duda, D. G., Jain, R. K., & Fukumura, D.
Venue
Clinical Cancer Research
Published
2016-06-14
Volume
22
Issue
12
Pages
2993-3004
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2276765336
Cited by
134
References
10
FWCI
9.25
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-15-1839
The paper
Incio, J., Tam, J., Rahbari, N. N., Suboj, P., McManus, D. T., Chin, S. M., Vardam, T. D., Batista, A., Babykutty, S., Jung, K., Khachatryan, A., Hato, T., Ligibel, J. A., Krop, I. E., Puchner, S. B., Schlett, C. L., Hoffmman, U., Ancukiewicz, M., Shibuya, M., . . . Fukumura, D. (2016). PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-15-1839

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.